Our findings provide direct in vivo evidence for the involvement of estrogen suppression in SERT deficiency-induced obesity and glucose intolerance and suggest therapeutic implications for SERT deficiency-associated metabolic abnormalities. The gene discussed is SLC6A4; the disease is hyperinsulinemic hypoglycemia, familial, 4.